Cite
Ansari M, Omidvari S, Mosalaei A, et al. A Phase II Study of Docetaxel, Cisplatin and 5- Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas. Iran Red Crescent Med J. 2011;13(3):187-91
Ansari, M., Omidvari, S., Mosalaei, A., Ahmadloo, N., Mosleh-Shirazi, M. A., & Mohammadianpanah, M. (2011). A Phase II Study of Docetaxel, Cisplatin and 5- Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas. Iranian Red Crescent medical journal, 13(3), 187-91.
Ansari, M, et al. "A Phase II Study of Docetaxel, Cisplatin and 5- Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas." Iranian Red Crescent medical journal vol. 13,3 (2011): 187-91.
Ansari M, Omidvari S, Mosalaei A, Ahmadloo N, Mosleh-Shirazi MA, Mohammadianpanah M. A Phase II Study of Docetaxel, Cisplatin and 5- Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas. Iran Red Crescent Med J. 2011 Mar;13(3):187-91. Epub 2011 Mar 01. PMID: 22737461; PMCID: PMC3371950.
Copy
Download .nbib